Comparative pharmacology of H1 antihistamines: clinical relevance
- 1 December 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (9) , 38-46
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjectsAnnals of Allergy, Asthma & Immunology, 2002
- Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test systemAnnals of Allergy, Asthma & Immunology, 2001
- Skin concentrations of H1-receptor antagonistsJournal of Allergy and Clinical Immunology, 2001
- DesloratadineDrugs, 2001
- A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Topical azelastine has a 12‐hour duration of action as assessed by histamine challenge‐induced exudation of α2‐macroglobulin into human nasal airwaysClinical & Experimental Allergy, 1997
- The clinical pharmacology of fexofenadine in childrenJournal of Allergy and Clinical Immunology, 1996
- LoratadineDrugs, 1994
- CetirizineDrugs, 1993
- AcrivastineDrugs, 1991